Pentedrone

Pentedrone (alpha-methylaminovalerophenone, α-methylaminovalerophenone) is a synthetic stimulant of the cathinone chemical class, structurally related to cathinone and methcathinone through the substitution of the beta-keto carbon chain with a pentanophenone backbone. It is one of the simpler members of the cathinone NPS family and is considered a structural precursor or analog of both A-PVP (which adds a pyrrolidine ring) and hexedrone (which extends the chain by one carbon).

Pentedrone acts as a dopamine and norepinephrine reuptake inhibitor, producing predominantly stimulant effects: energy, focus, mild euphoria, cardiovascular activation, and appetite suppression. It lacks meaningful serotonergic activity, reflecting the absence of methylenedioxy or methoxy ring features associated with SERT activity in this compound class. The subjective experience is characterized as a moderately potent cathinone stimulant — more intense than simple cathinone itself but without the extreme compulsive properties of high-potency pyrrolidine analogs.

Community experience with pentedrone includes Reddit discussions about its analogs — halogenated pentedrone modifications and theoretical synthesis of N-ethylnorpentedrone — reflecting interest in this compound as a structural foundation for further modification. This interest in modification pathways mirrors the broader designer drug research ecosystem that has made pentedrone a structural reference point in the cathinone chemistry literature.

Pentedrone's harm profile is consistent with other moderate-potency NDRI cathinones: cardiovascular stimulation, sleep disruption, compulsive redosing potential, and at high doses or in extended use, anxiety and paranoia. Community accounts of cathinone comedowns apply directly. The absence of meaningful serotonergic activity reduces the serotonin syndrome risk compared to MDxx cathinones, but MAOI combination remains contraindicated due to noradrenergic activity.